Who is sponsoring NCT04758728?

NCT04758728 is sponsored by Junior Doctors Network-Hellas.

What condition does NCT04758728 study?

NCT04758728 studies Venous Insufficiency (Chronic)(Peripheral), Venous Reflux, Venous Insufficiency of Leg, Venous Stasis, Venous Disease, Subcutaneous Haematoma, Ecchymosis, Bruising.

Is NCT04758728 still recruiting?

NCT04758728 is currently completed. Last updated 18 February 2021.

Last reviewed 2021-02-18 · How we verify

NCT04758728: ARESQOLSAVES

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping

Completed NA Last updated 18 February 2021

What this trial tests

NA trial testing Great saphenous vein stripping and varicectomies in Venous Insufficiency (Chronic)(Peripheral) in 40 participants. Completed in 10 June 2016.

Timeline

10 September 2015

Primary endpoint
14 May 2016

10 June 2016

Quick facts

Lead sponsor	Junior Doctors Network-Hellas
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	40
Start date	10 September 2015
Primary completion	14 May 2016
Estimated completion	10 June 2016
Sites	1 location across Greece

Drugs / interventions tested

Great saphenous vein stripping and varicectomies
Epinephrine Topical — full drug profile →
normal saline

Conditions studied

Venous Insufficiency (Chronic)(Peripheral) — all drugs for Venous Insufficiency (Chronic)(Peripheral) →
Venous Reflux — all drugs for Venous Reflux →
Venous Insufficiency of Leg — all drugs for Venous Insufficiency of Leg →
Venous Stasis — all drugs for Venous Stasis →

Sponsor

Junior Doctors Network-Hellas

Who can join

Adults 18 to 80, any sex, with Venous Insufficiency (Chronic)(Peripheral) or Venous Reflux. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the present study is to investigate the efficiency of adrenaline (epinephrine) used locally in reducing and avoiding post-operative formation of subcutaneous ecchymoses and hematomas, in comparison with traditional practice of hemostasis, and to assess improvement in the quality of life of subjects undergoing classic great saphenous vein stripping, who received or did not receive adrenaline as a local hemostatic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04758728 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Junior Doctors Network-Hellas
Last refreshed: 18 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04758728.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing